AXSM Axsome Therapeutics Inc Earnings per share for the last twelve months
Axsome Therapeutics (AXSM) is building on the success of Auvelity and Sunosi by expanding the list of indications for the treatment of migraine and Alzheimer's disease. Net income per share over the last 12 months confirms the resilience of the model, where the parameter value reaches -3.06. Returns are based on partnerships with research organizations, while the active penetration of new sales markets ensures a steady influx of patients.
Axsome (AXSM) - metric breakdowns and financial figures
- current quotes and average value forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Equity Ratio Axsome Therapeutics|AXSM - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Axsome Therapeutics Inc|AXSM - Aggregate Debt Obligations|Debts to Book Capitalization Axsome Therapeutics, Inc.|AXSM - Long-Term Debt|Company Short-Term Debt Axsome Therapeutics|Quick Ratio axsome.com
- net income and valuation multiples indicators:
AXSM - Net Profit|Expected Profit Axsome Therapeutics|AXSM - Market Cap to Net Income|Forward P/E Multiple Axsome Therapeutics, Inc.|AXSM - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Axsome Therapeutics, Inc.|AXSM - Operating profit EBITDA|Net earnings per share for the last 12 months Axsome Therapeutics|AXSM - Earnings per share for the last four quarters|Quarterly EPS earnings growth axsome.com|AXSM - Expected net earnings per share growth this year|Earnings growth forecast for next year Axsome Therapeutics
General company analysis:Axsome Therapeutics (AXSM)
Investors utilize this indicator as the primary marker of return on equity, assessing the portion of net income attributable to a single common share. The calculation logic for the current EPS TTM level is based on total annual income, which for Axsome Therapeutics (AXSM) confirms the effectiveness of commercializing migraine and depression treatments, creating an internal growth driver independent of macroeconomic fluctuations.
Main competitors
BIIB - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months neurocrine.com|Regencell Bioscience Holdings Limited (RGC) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ACADIA Pharma|XENE (Xenon Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Viking Therapeutics Corp VKTX|Net earnings per share for the last 12 months SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Earnings per share for the trailing year|Denali Therapeutics Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AMLX (Amylyx Corp)|TRVI: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months praxismedicines.com (PRAX)|Earnings per share for the last twelve months Anavex Life Sciences Corp.|CBLL: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRTA|Net earnings per share (EPS TTM) alector.com (ALEC)|Earnings per share for the last twelve months Annexon, Inc. ANNX|OMER (Omeros Corp) - Earnings per one share for the last 12 months|Neurogene - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AC Immune S.A.|VYGR (Voyager Pharma) - Net earnings per share for the last 12 months|Neumora Corp (NMRA) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months SCLX|TVGN (tevogen.com) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ACOG|Net earnings per share for the last four quarters Cognition Therapeutics Inc.|Net earnings per share (EPS TTM) IKT (Inhibikase)|SAVA - Net earnings per share for the last 12 months|ASRT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Coya Therapeutics, Inc. COYA|VTGN: Net earnings per share (EPS TTM)|Ovid Therapeutics (OVID) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ABOS|Earnings per share for the last 12 months CRVO (CervoMed Corporation)|Earnings per share for the last twelve months Alterity Therapeutics (ATHE)|Net earnings per share for the last four quarters clene.com|Earnings per share for the last twelve months PepGen PEPG|JUNS - Net earnings per share for the last 12 months|RLMD - Earnings per share for the last twelve months|ANVS (Annovis Bio Corporation) - Earnings per share for the last 12 months|GRCE: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months fireflyneuro.com (AIFF)|Net earnings per share for the last 12 months KLTO|Net earnings per share (EPS TTM) NeuroSense Therapeutics, Ltd.|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings (RVPH)|MTVA (metaviatx.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months NeurAxis, Inc. NRXS|Helius Medical Technologies, Inc. (HSDT) - Net earnings per one share for the last twelve months|Passage Bio Corp - Net earnings per share (EPS TTM)|NEUP - Net earnings per share (EPS TTM)|NERV (Minerva Neurosciences Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ATHA|Earnings per share for the last twelve months Addex Therapeutics|Alzamend (ALZN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Pasithea Therapeutics Corp. KTTA|CRGT - Net earnings per share for the last 12 months|Avenue Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months brainstorm-cell.com|CARA (Cara Therapeutics) - Net earnings per share for the last 12 months|Chromocell Therapeutics Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ELYM|ITCI (Intra-Cellular) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) LBPH|MRNS (marinuspharma.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NKGN (NKGen Biotech)|NeuroBo Pharmaceuticals Inc (NRBO) - Net earnings per one share for the last twelve months|SAGE - Earnings per share for the last twelve months|Earnings per share for the trailing year SNPX (Synaptogenix, Inc)|TRVN: Net earnings per share (EPS TTM)|Vigil Neuroscience, Inc. (VIGL) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Anew Medical|Cerevel Therapeutics Inc - Earnings per one share for the last 12 months
